Choi KH, Groarke JM, Young DC, Pevear DC, Rossmann MG, Kuhn RJ, Smith JL (2004) Design, expression, and purification of a Flaviviridae polymerase using a high-throughput approach to facilitate crystal structure determination. Protein Science 13 (10) My research area of interest is in Bioinformatics with special considerations given to the mathematical discovery of biomarkers. Using the tools of mathematical modeling and machine learning, I am able to create classifiers to accurately predict disease outcome, discover the best treatment options for disease, examine disease prognosis, or learn more about drug discovery. The methods of machine learning allow for multiple types of input, which make it extremely well-suited for use in a clinical/translational setting. I have been working with support vector machines (SVMs) which operate by finding a separating hypersurface (think: a line in multidimensional space) to accurately distinguish one group from another. The theory behind machine learning algorithms is that by utilizing both a training set and a testing set of data, one can check the accuracy of the classifier or model to build the best possible set of biomarkers. Once the classifier has been created, researchers can use it to predict the outcome or best treatment options for future patients. SVMs operate by utilizing a kernel function to discriminate between groups of data. The beauty of this kernel function is that it provides a stable platform so that the model will always converge and it also projects the data onto higher dimensional space so that you will always be able to find linearly separable groups. Some important features of support vector machines are that they are data independent -they work for multiple types of data sources as well as combinations of data at once. They also use a linear separation to solve nonlinear problems.
Also, congratulations are in order to our assistant professor, Dr. Olivera Nesic. She has been awarded the 2007 Erica Nader Award by the American Spinal Injury Association (ASIA), ASIA's most prestigious award sponsored by Viscogliosi Brothers, for her outstanding work in the area of proteins that contribute to edema and syringomyelia after spinal cord injury. The award will be presented at the annual ASIA meeting in Tampa in June. Well done, Olivera! Enjoy the spring weather! regino A busy March indeed, with adjustments of grant submission deadlines, not to mention new time changes. After months of work and two faculty meetings, a modified faculty compensation plan for tenure track faculty has been submitted to the faculty and approved. Once approved by the Dean of the School of Medicine, this would be put in effect for next year. Also, we will make sure to review the document on a regular basis to make sure that it remains a useful instrument. We now have a committee that is addressing the role of the non-tenure track faculty. More to come on this issue. UTMB has received $30 million in PUF funds for a research building and has requested $60 million more. Given that a new president is coming on board, we are told it is very likely we will receive the additional funds. This will enable construction of a research building of about 150,000 square feet.
It has been proposed that in the future, access to Clay Hall will require a properly activated UTMB ID, as is the case now for Basic Sciences and the Blocker MRB. This is being done at the request of our colleagues working there. We will announce the change in access as soon as it is implemented.
If any of our faculty are planning to submit a grant for a June deadline and you wish to make a "presubmission" to our in-house Study Section, please let David Konkel or myself know as soon as possible. It will take some planning to assemble the reviewers and block time on their calendars for this function. The draft version will receive the equivalent of a Study Section review by faculty who have Study Section experience. If you are not sure if this would be of help to you, feel free to contact me and we will discuss it. Our research focuses on the structure and mechanism of viral replication and infection machinery using X-ray crystallography and cryo-electron microscopy. Atomic resolution structures of large complexes (up to several thousand Å in diameter) can be obtained by the combination of these two techniques.
Virtually all RNA viruses carry out viral genome replication using a large replication complex composed of RNA, viral replicases (i.e., polymerase, helicase, protease), and cellular proteins. However, specific protein-protein and protein-RNA interactions are still poorly understood. We are interested in the structure of individual replication enzymes and their protein-protein, and protein-RNA complexes in human and animal viruses. These viruses include hepatitis C virus, bovine viral diarrhea virus (BVDV), dengue virus, human coronavirus (SARS), and hantan virus. Our structural studies will help develop antiviral therapeutics for animal and human diseases caused by these RNA viruses.
Tailed bacteriophages have to deliver their genetic information into the host cell's cytoplasm across cell membranes. The tail machinery, composed of multiple protein components, attaches to the cell membrane and transports genomic DNA into the cell. We use bacteriophage N4 as a model system to study the mechanism of genome and protein transport from the virus into the host cell. N4 packages dsDNA as well as one or two copies of a 3,500-amino acid RNA polymerase inside the capsid, which is then ejected into host cell upon infection. In collaboration with Dr. Lucia Rothman-Denes laboratory (University of Chicago), we are determining the structure of N4 virions, including their tail component proteins. My research area of interest is in Bioinformatics with special considerations given to the mathematical discovery of biomarkers. Using the tools of mathematical modeling and machine learning, I am able to create classifiers to accurately predict disease outcome, discover the best treatment options for disease, examine disease prognosis, or learn more about drug discovery. The methods of machine learning allow for multiple types of input, which make it extremely well-suited for use in a clinical/translational setting. I have been working with support vector machines (SVMs) which operate by finding a separating hypersurface (think: a line in multidimensional space) to accurately distinguish one group from another. The theory behind machine learning algorithms is that by utilizing both a training set and a testing set of data, one can check the accuracy of the classifier or model to build the best possible set of biomarkers. Once the classifier has been created, researchers can use it to predict the outcome or best treatment options for future patients. SVMs operate by utilizing a kernel function to discriminate between groups of data. The beauty of this kernel function is that it provides a stable platform so that the model will always converge and it also projects the data onto higher dimensional space so that you will always be able to find linearly separable groups. Some important features of support vector machines are that they are data independent -they work for multiple types of data sources as well as combinations of data at once. They also use a linear separation to solve nonlinear problems.
I am also actively involved in developing methods to combine various types of data as well as optimizing the kernel functions which are at the heart of the machine learning algorithms. I initiated a biomarkers workgroup which meets once a week to discuss applications and algorithms for investigation. Machine learning algorithms, and specifically SVMs, have been shown to work well for protein-protein interaction prediction, gene functional classification from microarray data, cancer classification from omics data, splice site recognition, protein sequence similarity detection, protein functional classification, and regulatory module searches among others. If anyone is interested in attending the biomarkers workgropu, or has a project that you think would benefit from these methods, please feel free to contact me hespratt@utmb.edu, x 28100. (The specific periods are slightly different for weekly and bi-weekly faculty and staff.) Although OSP stipulates that the reports should be completed within 30 days, we are asking BMB personnel to complete the reports on or before Monday, April 13. Because there have been certain difficulties with implementation of the new salary/payroll system, we will be sampling some of the time-and-effort reports to confirm that the salary information presented in the system is correct. If any inconsistencies are noted, we will review the report with the individual faculty or staff member to determine whether any corrections might be needed. Thanks to everyone involved for your anticipated cooperation on this critically important task.
Temporary Administrative Staff
To help us keep the administrative machinery going while we are short of regular staff, we have recruited two and a half temporary secretaries. Sher Owen is working full-time at Diane Strain's desk assisting Dr. Papaconstantinou and Dr. Carney and performing work in Peoplesoft, especially with placing certain orders. Aurora Ruiz is using the desk just inside 107 Basic Science Building. She is working full-time providing essential administrative services for Dr. Braun, Dr. Schein, and soon Dr. Gorenstein, as well as assisting me in covering the more complex tasks of managing grants for those faculty members. Ana Lyons is working part-time on special administrative projects relating to faculty recruitment, preparation of records for archiving, and data entry for major reports. All three secretaries have learned about the Department very quickly and began right away to shoulder as much of the workload as they could. We appreciate the assistance that Department members have provided in helping them become oriented to BMB operations.
Important Accomplishment by Steve Hathorn
Steve Hathorn has been instrumental in preparing the lab suite on the second floor of BSB, formerly assigned to the Molecular Biology Training Lab, for conversion to other uses. Steve has organized and managed distribution of the equipment and supplies; taken care of disposing of chemicals and other remaining items appropriately; and coordinated work by FOAM to prepare the space for the transition in use. This is an example of the out-of-the-ordinary tasks that seem to come up with some frequency in a complex department such as this one, and we know we can count on Steve to handle these types of things with efficiency and appropriate attention to detail. Thank you for all your efforts on this, Steve.
-Marianne
Administrator's Notes An in vitro assembly system was developed to study prolate capsid assembly of phage ø29 biochemically, and to identify regions of scaffolding protein required for its functions. The crowding agent polyethylene glycol can induce bacteriophage ø29 monomeric capsid protein and dimeric scaffolding protein to co-assemble to form particles which have the same geometry as either prolate T = 3 Q = 5 procapsids formed in vivo or previously observed isometric particles. The formation of particles is a scaffolding-dependent reaction. The balance between the fidelity and efficiency of assembly is controlled by the concentration of crowding agent and temperature. The assembly process is salt sensitive, suggesting that the interactions between the scaffolding and coat proteins are electrostatic.
Three N-terminal ø29 scaffolding protein deletion mutants, Δ 1-9, Δ 1-15 and Δ 1-22, abolish the assembly activity. Circular dichroism spectra indicate that these N-terminal deletions are accompanied by a loss of helicity. The inability of these proteins to dimerize suggests that the N-terminal region of the scaffolding protein contributes to the dimer interface and maintains the structural integrity of the dimeric protein.
Two C-terminal scaffolding protein deletion mutants, Δ 79-97 and Δ 62-97, also fail to promote assembly. However, the secondary structure and the dimerization ability of these mutants are unchanged relative to wild-type, which suggests that the C terminus is the likely site of interaction with the capsid protein.
